For diabetes treatment, NICE recommends continuing GLP-1 therapy only if HbA1c has fallen by at least 11 mmol/mol (1%) and weight has reduced by at least 3% after approximately 6 months, unless there are individual clinical reasons to continue
The complete list of injectable peptides , the guide to the best peptides for weight loss , and resources on peptides for weight loss provide the foundational knowledge that makes everything else click into place
Given the short timeframe of the GLP-1 demonstration, it is unlikely that there will be cost offsets from improved health due to increased GLP-1 use for obesity that can be documented
References: HIGHLIGHTS OF PRESCRIBING INFORMATION, Accessdata.fda.gov,
Injury Recovery : Its also been shown to speed up the healing of wounds and injuries, which is useful if youve been sidelined by a strain or tear